WO2003042694B1 - Characterization of molecules - Google Patents
Characterization of moleculesInfo
- Publication number
- WO2003042694B1 WO2003042694B1 PCT/US2002/036519 US0236519W WO03042694B1 WO 2003042694 B1 WO2003042694 B1 WO 2003042694B1 US 0236519 W US0236519 W US 0236519W WO 03042694 B1 WO03042694 B1 WO 03042694B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- species
- biomolecule
- biomolecules
- signature
- bound
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
Abstract
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE60235642T DE60235642D1 (en) | 2001-11-12 | 2002-11-12 | CHARACTERIZATION OF MOLECULES |
AT02795636T ATE460665T1 (en) | 2001-11-12 | 2002-11-12 | CHARACTERIZATION OF MOLECULES |
JP2003544476A JP2005509856A (en) | 2001-11-12 | 2002-11-12 | Molecular characterization |
CA002466663A CA2466663A1 (en) | 2001-11-12 | 2002-11-12 | Characterization of molecules |
EP02795636A EP1444515B1 (en) | 2001-11-12 | 2002-11-12 | Characterization of molecules |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33689501P | 2001-11-12 | 2001-11-12 | |
US60/336,895 | 2001-11-12 | ||
US35247302P | 2002-01-28 | 2002-01-28 | |
US60/352,473 | 2002-01-28 | ||
US36166102P | 2002-03-04 | 2002-03-04 | |
US60/361,661 | 2002-03-04 | ||
US41275402P | 2002-09-23 | 2002-09-23 | |
US60/412,754 | 2002-09-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003042694A2 WO2003042694A2 (en) | 2003-05-22 |
WO2003042694A3 WO2003042694A3 (en) | 2004-02-26 |
WO2003042694B1 true WO2003042694B1 (en) | 2004-04-08 |
Family
ID=27502555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/036519 WO2003042694A2 (en) | 2001-11-12 | 2002-11-12 | Characterization of molecules |
Country Status (8)
Country | Link |
---|---|
US (3) | US7968350B2 (en) |
EP (1) | EP1444515B1 (en) |
JP (1) | JP2005509856A (en) |
AT (1) | ATE460665T1 (en) |
CA (1) | CA2466663A1 (en) |
DE (1) | DE60235642D1 (en) |
ES (1) | ES2342713T3 (en) |
WO (1) | WO2003042694A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003016883A1 (en) | 2001-08-16 | 2003-02-27 | Analiza, Inc. | A method of measuring solubility |
WO2003042694A2 (en) | 2001-11-12 | 2003-05-22 | Analiza, Inc. | Characterization of molecules |
US7024955B2 (en) | 2003-03-01 | 2006-04-11 | Symyx Technologies, Inc. | Methods and systems for dissolution testing |
US8099242B2 (en) | 2003-06-12 | 2012-01-17 | Analiza, Inc. | Systems and methods for characterization of molecules |
US20060155186A1 (en) * | 2005-01-12 | 2006-07-13 | James Timothy W | Bone health assessment using spatial-frequency analysis |
WO2007062255A2 (en) * | 2005-11-27 | 2007-05-31 | Osteotronix, Limited | Assessment of structures such as bone using spatial-frequency analysis |
AU2006345702B2 (en) | 2005-12-19 | 2012-11-29 | Analiza, Inc. | Systems and methods involving data patterns such as spectral biomarkers |
WO2007139037A1 (en) * | 2006-05-26 | 2007-12-06 | Kyoto University | Estimation of protein-compound interaction and rational design of compound library based on chemical genomic information |
US20110105855A1 (en) * | 2009-10-30 | 2011-05-05 | Trustees Of Tufts College | Early detection of cognition impairment in elderly population |
US10613087B2 (en) | 2012-08-10 | 2020-04-07 | Analiza, Inc. | Methods and devices for analyzing species to determine diseases |
US9678076B2 (en) * | 2014-06-24 | 2017-06-13 | Analiza, Inc. | Methods and devices for determining a disease state |
US10957421B2 (en) | 2014-12-03 | 2021-03-23 | Syracuse University | System and method for inter-species DNA mixture interpretation |
US11150181B2 (en) * | 2017-12-05 | 2021-10-19 | Jp3 Measurement, Llc | Method for computing and comparing digital signatures of hydrocarbons |
AU2021227930A1 (en) | 2020-02-28 | 2022-09-15 | Analiza, Inc. | Systems and methods for determining viruses such as coronaviruses |
US11535902B2 (en) | 2021-03-17 | 2022-12-27 | Analiza, Inc. | RNA separation and related techniques for determining viruses such as coronaviruses |
US11796544B1 (en) | 2021-10-28 | 2023-10-24 | Analiza, Inc. | Partitioning systems and methods for determining multiple types of cancers |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5008204A (en) * | 1988-02-02 | 1991-04-16 | Exxon Chemical Patents Inc. | Method for determining the compositional distribution of a crystalline copolymer |
US5340474A (en) * | 1988-03-24 | 1994-08-23 | Terrapin Technologies, Inc. | Panels of analyte-binding ligands |
US5241072A (en) * | 1990-05-25 | 1993-08-31 | Genzyne Corporation | Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof |
US5311131A (en) * | 1992-05-15 | 1994-05-10 | Board Of Regents Of The University Of Washington | Magnetic resonance imaging using pattern recognition |
AU1837495A (en) * | 1994-10-13 | 1996-05-06 | Horus Therapeutics, Inc. | Computer assisted methods for diagnosing diseases |
US5837203A (en) * | 1996-04-09 | 1998-11-17 | Sievers Instruments, Inc. | Device to alternately supply a fluid to an analyzer |
US5734024A (en) * | 1996-04-19 | 1998-03-31 | Boris Y. Zaslavsky | Method for determining the biological activity of recombinant human growth hormone |
US5948750A (en) * | 1996-10-30 | 1999-09-07 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
WO1998046756A1 (en) * | 1997-04-16 | 1998-10-22 | Millennium Biotherapeutics | Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor |
AU8911998A (en) | 1997-08-19 | 2000-03-14 | Arnon Chait | Method for evaluation of the ratio of amounts of biomolecules or their sub-populations in a mixture |
AU736198B2 (en) * | 1997-08-22 | 2001-07-26 | Purdue Research Foundation | Drug discovery using multiple membrane mimetic affinities |
DE19903576C2 (en) * | 1999-01-29 | 2001-02-22 | Bodenseewerk Perkin Elmer Co | Quantitative determination of analytes in a heterogeneous system |
US6451849B1 (en) * | 1999-03-30 | 2002-09-17 | Hormos Nutraceutical Oy Ltd. | Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
CA2382436C (en) * | 1999-08-30 | 2011-05-17 | Illumina, Inc. | Methods for improving signal detection from an array |
EP1250587A1 (en) | 2000-01-28 | 2002-10-23 | Pion, Inc. | MEASUREMENT OF SOLUBILITY-pH PROFILES |
US9709559B2 (en) * | 2000-06-21 | 2017-07-18 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
US20020102577A1 (en) * | 2000-07-31 | 2002-08-01 | Raillard Sun Ai | Nucleotide incorporating enzymes |
GB0031566D0 (en) * | 2000-12-22 | 2001-02-07 | Mets Ometrix | Methods for spectral analysis and their applications |
WO2003016883A1 (en) | 2001-08-16 | 2003-02-27 | Analiza, Inc. | A method of measuring solubility |
WO2003042694A2 (en) | 2001-11-12 | 2003-05-22 | Analiza, Inc. | Characterization of molecules |
US20040236603A1 (en) * | 2003-05-22 | 2004-11-25 | Biospect, Inc. | System of analyzing complex mixtures of biological and other fluids to identify biological state information |
WO2004111655A1 (en) | 2003-06-12 | 2004-12-23 | Analiza, Inc. | Systems and methods for characterization of molecules |
US8099242B2 (en) * | 2003-06-12 | 2012-01-17 | Analiza, Inc. | Systems and methods for characterization of molecules |
US20050100967A1 (en) | 2003-07-11 | 2005-05-12 | Science & Technology Corporation @ Unm | Detection of endometrial pathology |
US7391016B2 (en) | 2005-05-12 | 2008-06-24 | Analiza, Inc. | Method for quantitative analysis of mixtures of compounds |
US20070048786A1 (en) | 2005-09-01 | 2007-03-01 | Arnon Chait | Systems and methods for fractionation of protein mixtures |
AU2006345702B2 (en) | 2005-12-19 | 2012-11-29 | Analiza, Inc. | Systems and methods involving data patterns such as spectral biomarkers |
-
2002
- 2002-11-12 WO PCT/US2002/036519 patent/WO2003042694A2/en active Application Filing
- 2002-11-12 US US10/293,959 patent/US7968350B2/en active Active
- 2002-11-12 JP JP2003544476A patent/JP2005509856A/en not_active Withdrawn
- 2002-11-12 DE DE60235642T patent/DE60235642D1/en not_active Expired - Lifetime
- 2002-11-12 CA CA002466663A patent/CA2466663A1/en not_active Abandoned
- 2002-11-12 ES ES02795636T patent/ES2342713T3/en not_active Expired - Lifetime
- 2002-11-12 EP EP02795636A patent/EP1444515B1/en not_active Expired - Lifetime
- 2002-11-12 AT AT02795636T patent/ATE460665T1/en not_active IP Right Cessation
-
2011
- 2011-05-18 US US13/110,345 patent/US8211714B2/en not_active Expired - Lifetime
-
2012
- 2012-06-05 US US13/488,674 patent/US20120245856A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60235642D1 (en) | 2010-04-22 |
EP1444515A2 (en) | 2004-08-11 |
US20030162224A1 (en) | 2003-08-28 |
WO2003042694A3 (en) | 2004-02-26 |
US7968350B2 (en) | 2011-06-28 |
JP2005509856A (en) | 2005-04-14 |
WO2003042694A2 (en) | 2003-05-22 |
CA2466663A1 (en) | 2003-05-22 |
US8211714B2 (en) | 2012-07-03 |
ATE460665T1 (en) | 2010-03-15 |
EP1444515B1 (en) | 2010-03-10 |
US20120245856A1 (en) | 2012-09-27 |
ES2342713T3 (en) | 2010-07-13 |
US20110218738A1 (en) | 2011-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003042694B1 (en) | Characterization of molecules | |
Mateus et al. | Thermal proteome profiling for interrogating protein interactions | |
Banker et al. | Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding | |
Milburn et al. | Application of metabolomics to diagnosis of insulin resistance | |
US6924115B2 (en) | Process for identifying cell-specific target structures | |
Wolf-Yadlin et al. | Dissecting protein function and signaling using protein microarrays | |
Marko-Varga et al. | Proteomics and disease the challenges for technology and discovery | |
AU2006345702B2 (en) | Systems and methods involving data patterns such as spectral biomarkers | |
Colclough et al. | Species differences in drug plasma protein binding | |
Poole et al. | Quantitative structure–retention (property) relationships in micellar electrokinetic chromatography | |
WO2004062553A3 (en) | Affinity screening using “one-bead-one-compound” libraries | |
Caron et al. | A fast chromatographic method for estimating lipophilicity and ionization in nonpolar membrane-like environment | |
Yeung et al. | Separation orthogonality in liquid chromatography–mass spectrometry for proteomic applications: comparison of 16 different two-dimensional combinations | |
Wang et al. | Determination of the secondary structure of proteins in different environments by FTIR‐ATR spectroscopy and PLS regression | |
Galbusera et al. | Molecular interaction in capillary electrophoresis | |
Hidalgo-Rodriguez et al. | Modeling nonspecific toxicity of organic compounds to the fathead minnow fish by means of chromatographic systems | |
Ruiz-Godoy et al. | Identification of specific pre-analytical quality control markers in plasma and serum samples | |
Rodgers et al. | Time‐series QSAR analysis of human plasma protein binding data | |
Rambaldi et al. | An analytical method for size and shape characterization of blood lipoproteins | |
Marlot et al. | In silico screening of comprehensive two-dimensional centrifugal partition chromatography× liquid chromatography for multiple compound isolation | |
Haeckel | Recommendations for definition and determination of carry-over effects | |
Bujalowski et al. | Quantitative thermodynamic analyses of spectroscopic titration curves | |
Hartmann et al. | ADME related profiling in 96 and 384 well plate format-a novel and robust HT-assay for the determination of lipophilicity and serum albumin binding | |
Helmersson‐Karlqvist et al. | The Roche immunoturbidimetric albumin method on Cobas c 501 gives higher values than the Abbott and Roche BCP methods when analyzing patient plasma samples | |
Zeneyedpour et al. | Phosphorylation ratio determination in fresh-frozen and formalin-fixed paraffin-embedded tissue with targeted mass spectrometry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
B | Later publication of amended claims |
Effective date: 20040218 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2466663 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003544476 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002360385 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002795636 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002795636 Country of ref document: EP |